| South African Rheumatism and Arthritis Association | ||
| Motivation form for COXIBS | ||
|
Doctor's name |
Patient name | |
| Address | Reference number | |
| Address | ||
| Phone number | ||
| Fax number | Phone number | |
| Medical aid | Number | |
| Requested Drug | Celecoxib / Celebrex | Rofecoxib / Vioxx | ||
Reason |
||||
|
Diagnosis |
Risk factor / Failed or intolerance to other NSAIDs |
|||
|
Factors |
Detail | |||
| Rheumatoid arthritis | Age | |||
| Osteoarthritis | Sex | |||
| Spondyloarthropathy | Corticosteroid therapy | |||
| Ankylosing Spondylitis | Previous Ulcer | |||
| Psoriatic Arthritis | Previous GI haemorrhage | |||
| Reiter / Reactive arthritis | Warfarin | |||
| Trauma | ||||
| Other | Previous intolerance | |||
| Other | ||||
Whereas all patients with chronic rheumatic conditions should
receive COXIBs rather than NSAIDs due to the superior safety of these
drugs, we recommend that these drugs should be mandatory in high risk
patients requiring chronic NSAIDs as identified below.
1. Patients over 60 years of age.
2. Patients with previous proven peptic ulceration.
3. Patients on chronic corticosteroids.
4. Patients on Warfarin. It is suggested that where Healthcare Funders
are unable to meet the financial obligation of chronic COXIB usage that
the patient be given the option of contributing the extra cost above
that of a standard NSAID.